Breast Cancer Clinical Trial
Official title:
DTi Diffusion Findings in Breast MRI Screening and Diagnostic
Introduction The most common breast cancer originates within the breast milk ducts, and is
called ductal carcinoma. After the stage where the cancer is found only within the ducts, it
invades the breast tissue beyond the ducts, and becomes invasive cancer (Infiltrating Duct
Carcinoma). Breast cancer located within the ducts is called intra ductal carcinoma in situ-
DCIS. DCIS is the developing cancer and usually does not metastasize. Another type of breast
cancer originates within the breast lobules and is call lobular carcinoma.
Recently at the Weizmann Institute, Prof. Hadassa Degani and her group developed and imaging
technique using breast MRI. This technique allows to map the three-dimensional structure of
the milk ducts in the breast. The method is based on measuring the random movement (Brownian
motion) of water molecules (diffusion) in different directions in the breast tissue,
collecting diffusion images by using magnetic field gradients in different directions,
allowing imaging of Diffusion tensor Imaging -DTI. Movement of water molecules within a
unified solution is usually random and uniform in all directions, but the internal structures
in biological systems (such as cells, pipelines, fiber) restrict the movement of water in
certain directions. The DTI method exploits this feature by measuring the diffusion in
various directions, thus enabling calculating images of biological structures [1]. This
method was proved to be effective in mapping the brain's white matter fibers and is used
routinely in clinical tests used to monitor neurological injuries [2-4]. This method was used
for milk ducts mapping within breast tissue at the Weizmann Institute. The system that was
developed at the Weizmann Institute, showed that the movement of water molecules along the
milk ducts is faster than their movement across the ducts and therefore it was possible using
this method to map the breast ductal system. Also this method showed that it is possible to
detect and diagnose malignant changes within breast and to distinguish them from normal
tissue and benign tumors using DTI. Changes in cell density and arrangement causes changes in
the directional diffusion coefficients and the differences between them [5-9] Research Plan
Summary A prospective preliminary study to evaluate the correlation between the DTI analysis
of breast MRI and the results of conventional contrast enhanced breast MRI.
The patients enrolled for the study will be women scheduled for breast MRI due to high risk
screening or pretreatment evaluation. The patients will fill in a form regarding: age,
hormonal status, risk factors, prior breast surgery or treatment (a form which is routinely
filled out in our institution). They will then undergo a breast MRI scan, using the routine
protocol in our institution. This will be directly followed by a DTI sequence, which takes
about 10 minutes in addition to the regular examination. The DTI sequence is routinely used
in other imaging institutions, as part of the breast MRI protocol.
The exams will be read on our regular work stations, and in addition will be analyzed by
software developed at the Weizmann Institute. Both interpretations will then be compared to
each other and to clinical and pathological data
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
| Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
| Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
| Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
| Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
| Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
| Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
| Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
| Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
| Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
| Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
| Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
| Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
| Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
| Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
| Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A |